PDS Biotechnology Corp Non Peo Neo Avg Total Comp Amt
PDS Biotechnology Corp (PDSB) reported Non Peo Neo Avg Total Comp Amt of $675.47 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-06-26.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-06-26
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $675.47K DEF 14A · filed 2026-06-26 |
| 2024-12-31 | $1.13M DEF 14A · filed 2026-06-26 |
| 2023-12-31 | $1.81M DEF 14A · filed 2026-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |